Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy
To compare renal functional outcomes in patients with and without chronic kidney disease (CKD) to identify predictors of change in renal function after percutaneous nephrolithotomy (PCNL). We reviewed patients who underwent PCNL by a single surgeon over 3.5 years. Patients’ pre- and post-operative Glomerular Filtration Rate (GFR) was calculated. Baseline GFR < 60 ml/min/1.73 m2 (stage ≥ 3 CKD) defined our CKD cohort. Patients’ baseline renal function, comorbidities, stone parameters, and intra-operative variables were analyzed to determine the relationship with post-operative renal function after PCNL by multivariate analysis. 202 patients were analyzed. Mean follow-up time was 16 months. At baseline, 163 (80.7%) patients were free of CKD and 39 (19.3%) had CKD. Patients without CKD had an overall decrease in GFR from 105.6 to 103.3 ml/min/1.73 m2 (p = 0.494). 14/163 (8.6%) non-CKD patients experienced a significant decline in renal function after PCNL; 7/163 (4.3%) developed de novo CKD and 7 had a ≥ 30% decline in GFR. Patients with CKD had an overall increase in mean GFR post-operatively, from 47.3 to 54.0 ml/min/m2 (p = 0.067). Two in this cohort (5.1%) experienced a > 30% decline in renal function post-operatively. Age, gender, African American race, presence of comorbidities and pre-operative CKD were not significant predictors of renal function post-operatively on multivariate analysis. PCNL in this cohort appears GFR neutral in the setting of baseline CKD. CKD was not predictive of renal functional decline after PCNL. Given that stone disease carries a high recurrence rate and that CKD is associated with stone formers, further investigation into predictors of renal function change after PCNL is warranted.
KeywordsPCNL CKD Renal function Kidney stone
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Litwin M, Saigal C (2012) Economic impact of urologic disease, N.I.o.H. National Institute of Diabetes and Digestive and Kidney Diseases, US Department of Health and Human Services, Editor. 2012: Urologic Diseases in America. NIH Publication 12-7865, Washington, DC, p 486Google Scholar
- 12.Preminger GA, Lingerman JE, Nakada SY, Pearle MS, Wolf JS (2009) Report on the management of staghorn calculi (2005). Clinical guidelines 2005. https://www.auanet.org/education/guidelines/staghorn-calculi.cfm. Accessed 2015
- 23.Collins AJ et al (2011) US renal data system 2010 annual data report. Am J Kidney Dis 57(1 Suppl 1):A8 (e1–526) Google Scholar
- 26.Rosenberg M, Hsu CY (2004) Chronic kidney disease and progression. NephSAP 3(6):304–308Google Scholar